Assessing QbTest Utility in ADHD: A Randomised Controlled Trial
AQUA2
A RCT Comparing the Effects of Providing Clinicians and Patients With the Results of an Objective Measure of Activity and Attention (QbTest) Versus Usual Care on Diagnostic and Treatment Decision Making in Children and Young People With ADHD
1 other identifier
interventional
267
1 country
9
Brief Summary
Attention Deficit/Hyperactivity Disorder (ADHD)is one of the most common mental health disorders of childhood. Children with ADHD often have poor attention, are restless and hyperactive and show impulsive behaviour. It is important to detect ADHD so young people can have access to appropriate clinical interventions. One of the most common ways ADHD is assessed is through the clinician's opinion; however, this can vary between clinicians and is thought to be one reason why ADHD may be mis-diagnosed. Using a more objective computer tasks may help improve our understanding of ADHD. One computer task is the QbTest. The test presents different symbols to the child, and the child has to respond by pressing a button only when a target symbol appears. The test measures the child's attention, impulsivity and movement whilst doing this task. Although the test is thought to be a valid measure, more research needs to be conducted on this measure to see whether it helps clinicians decision making. To see whether this test helps clinicians make a diagnosis of ADHD and helps with medication decisions, children and young people will be asked to complete the task as part of their initial assessment for ADHD. Half the participants and their clinician will have access to the QbTest result; the other half will not have access to the QbTest result until the end of the study. Participant's parents, teachers and the clinician will also be asked to complete some questionnaires about the child's symptoms and behaviour. If the child is diagnosed with ADHD and is given medication they will be asked to complete the task again on medication. The same set of questionnaires will be completed by the parents/teachers/clinicians. The entire sample will be followed up at 6 months and asked to complete the questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2014
Typical duration for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 4, 2014
CompletedFirst Posted
Study publicly available on registry
August 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJune 22, 2016
June 1, 2016
1.9 years
August 4, 2014
June 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of clinic appointments until correct diagnosis confirmed
Number of clinic appointments until correct ADHD diagnosis is confirmed or excluded for the QBOpen (delivery of immediate QbTest feedback report) and QbBlind (delayed feedback of QbTest report) groups.
By 6 months
Secondary Outcomes (1)
Time to confirmation or exclusion of ADHD diagnosis (in days) and duration of clinic visits (in minutes).
Up to 6 months
Other Outcomes (2)
Degree of Confidence of diagnosis
Up to 6 months
Stability in diagnosis and confidence between the QbO and QbB group
Up to 6 months
Study Arms (2)
QB Open
ACTIVE COMPARATORParticipants and their clinician will receive results of the Qb Test
Qb Blind
OTHERParticipants and their clinician will be blind to the results of the Qb test
Interventions
Given to all participants but the results will be open or blind depending on arm allocation
Eligibility Criteria
You may qualify if:
- Age 6-17 years (may turn 18 years during the study).
- Referred to CAMHS or community paediatrics for an ADHD assessment
- Capable of providing written informed consent (over 16)
- Parental consent (under 16)
You may not qualify if:
- Non-fluent English
- Suspected moderate or severe learning disability
- Previous or current diagnosis of ADHD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Central Manchester University Hospitals NHS Foundation Trust
Manchester, Greater Manchester, M13 9WL, United Kingdom
Medway NHS Foundation Trust
Gillingham, Kent, ME7 5NY, United Kingdom
Bridgewater Community Healthcare NHS Trust
Wigan, Lancashire, WN3 6PR, United Kingdom
Leicestershire Partnership Nhs Trust
Leicester, Leicestershire, LE5 0TD, United Kingdom
United Lincolnshire Hospitals NHS Trust
Lincoln, Lincolnshire, LN2 4AX, United Kingdom
Alder Hey Children's NHS Foundation Trust
Liverpool, Merseyside, L12 2AP, United Kingdom
Nottinghamshire Healthcare Nhs Trust
Nottingham, Nottinghamshire, NG3 6AA, United Kingdom
Nottingham University Hospitals Nhs Trust
Nottingham, Nottinghamshire, NG7 2UH, United Kingdom
Sussex Partnership NHS Foundation Trust
Worthing, Sussex, BN13 3EP, United Kingdom
Related Publications (4)
Hall CL, Walker GM, Valentine AZ, Guo B, Kaylor-Hughes C, James M, Daley D, Sayal K, Hollis C. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial. BMJ Open. 2014 Dec 1;4(12):e006838. doi: 10.1136/bmjopen-2014-006838.
PMID: 25448628BACKGROUNDHall CL, Walker GM, Valentine AZ. Correction. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD - 'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial. BMJ Open. 2015 May 6;5(5):e006838corr1. doi: 10.1136/bmjopen-2014-006838corr1. No abstract available.
PMID: 25948406BACKGROUNDHollis C, Hall CL, Guo B, James M, Boadu J, Groom MJ, Brown N, Kaylor-Hughes C, Moldavsky M, Valentine AZ, Walker GM, Daley D, Sayal K, Morriss R; the AQUA Trial Group. The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial. J Child Psychol Psychiatry. 2018 Dec;59(12):1298-1308. doi: 10.1111/jcpp.12921. Epub 2018 Apr 26.
PMID: 29700813DERIVEDHall CL, Valentine AZ, Walker GM, Ball HM, Cogger H, Daley D, Groom MJ, Sayal K, Hollis C. Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach. BMC Psychiatry. 2017 Feb 10;17(1):66. doi: 10.1186/s12888-017-1222-5.
PMID: 28183284DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chris Hollis, MRC Psych, PhD
University of Nottingham, Nottingham HC Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2014
First Posted
August 5, 2014
Study Start
July 1, 2014
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
June 22, 2016
Record last verified: 2016-06